Malignant eccrine acrospiromas are rare. Clinica lly, they resemble other cutaneous lesions. A high index of suspicion must be maintained in cases of histologically benign eccrine acrospiromas fo r three reasons: (1) malignant transf ormation can occur, (2) the pr esence ofboth benign and malignant tissue can lead to a fal se-negative diagnosis if only the benign component is obtained in the biopsy specimen, and (3) benign-appearing tumors can recur locally or metastasize. The primary treatment is wide local excision with or without lymph node dissection. The efficacy of adjuvant chemotherapy and radiation therapy requiresf urther investigati on. We describe a case ofmalignant eccrine acrospiroma in an 80-year-old man, and we review the literature on this tumor, with emphasis on the differential diagnosis.
Introduction
A malignant eccrine acrospiroma (MEA) is a rare cutaneous tumor. These malign ancies are believed to originate in the sweat glands because of their strong reaction to eccrine enzymatic stains and their ultrastructural features seen on electron microscopy. 1 An MEA is also known as a malignant clear-cell hidradenoma, clear-cell hidradenocarcin oma, and malignant nodular hidradenoma.
Although malignant acrospiromas can occur in all regions of the body, they are slightly more common on the head and neck (30%) ando n the anterior trunk.i" Clini-cally, both malign ant and benign eccrine acrospi romas are painless, solitary, and firm dermal masses whose color varies (flesh-toned , red, blue, or brown) .1,2,5 Therefore, they cannot be distinguished by their clinical appearanc e alone.
Although benign acrospiromas have been widely reviewed, reports of their malign ant counterparts are rare. In this article, we describe a case of MEA, and we review the literature on this topic .
Case report
An 80-year-old black man came to the outp atient otolaryngology department with a 20-year history of a slowly growing lesion on the centr al scalp. He reported that the mass had been biop sied 3 years earlier and was found to be a seborrheic keratosi s. The patient complained of a new-on set bloody disch arge from the lesion in addition to the development of a parotid mass.
Physical examination revealed the presence of a 2 x 2em, ulcerated, mobile , nontender scalp mass, a right parotid mass, and supr aclavicular lymphad enopath y. A shave biopsy of the scalp lesion and fine-needle aspiration of the neck mass were performed . Histopathologic examination of the scalp specimen determined that it was an ulcerated, malignant tumor with featur es of both a benign and malignant neopl asm adjacent to each other (figure I). The malignant comp onent was consi stent with a poorly differenti ated adeno carcinoma (figures 2 and 3). Adjacent to the malignant cells were a few well-demarcated nodules of small, bland , polyhedral squamoid cells with focal duct formation (figures I and 4). Analysis of fineneedle aspiration materi al from the right cervical lymph node confirm ed the presence of a malignant neopla sm. Comput ed tomography (CT) of the head detected a mass overly ing the vertex of the skull without intracranial exten sion. CT of the neck demonstrated a I-em right cervical lymph node and a l-cm intraparotid mass. The patient was treated with wide local excision of the scalp lesion, right neck dissection (levels 1 through 5), and a superficial right parotidectomy. He was administered adjuvant radiotherapy in light of the histologic evidence of perineural and perivascular involvement (figure 5).
Two years later, the patient returned to the clinic with a firm, immobile mass that involved the left parotid gland along with cervical adenopathy in left levelS . Histopathologic analysis of a fine-needle aspiration biopsy specimen revealed that it also represented an MEA.
Discussion
MEA is a subtype of adenocarcinoma that originates in the eccrine glands. The diagnosis of MEA in this case was established by the presence of both a benign and malignant neoplasm in the same tumor-that is, there was a recognizable benign eccrine acrospiroma adjacent to the malignant tumor cells (figure 1). The malignant component of this tumor was characterized by solid, glandular, and papillary patterns and was histologically consistent with a poorly differentiated adenocarcinoma (figures 2 and 3).
On the basis of pathologic findings, the differential diagnoses include eccrine adenocarcinoma not otherwise specified (NOS), porocarcinoma, apocrine carcinoma, malignant chondroid syringoma, and eccrine spiradenoma. The tumor in our patient would have been classified as an eccrine adenocarcinoma NOS if the benign eccrine acrospiroma component had not been present. The diagnosis of eccrine adenocarcinoma NOS also requires the clinical exclusion of a cutaneous metastasis from an internal malignancy, such as a primary tumor in the gastrointestinal tract or lung. v' HOL DEN, COLOME-GRIMMER, SAVAG E, STIERMAN, POU Figure 5 . Perineura l invasion is seen in the surgica l specimen (arrolVs).
We considered the possibility of a porocarcinoma, the malign ant co unterpart of an eccrine poroma. Benign eccrine poromas and acrospiromas are related tumors with sim ilar cytolog ic features . Both contain small sq uamoid cells that rese mble those of sebo rrheic keratosis. A poroma is a superficial tum or confined to the epide rmis and upper dermis. An eccrine acrospiroma is a deep dermal or subcutaneous nodular neoplasm that is sometimes con nec ted to the epiderrnis.v? In retrospect, the part of our patient's biopsy specimen that was diagnosed as seborrheic keratosis was either a poroma or the superficial portion of a benign acrospiroma that was con nected to the epider mis. On e of the nodu les of the benign component in this case was located at the base of the bio psy spec ime n beneath the mal ign ant compo ne nt (ade noca rci noma). Th erefore, a diagnosis of MEA was favored over a diagnosis of porocarcinoma. Moreover, the malignant transformatio n in mos t porocarcinomas resembles tha t of a squamo us ce ll carcinoma rather than an adenocarcinoma, as was seen in our patient. 8 Apocrine carcinoma usually ar ises in the "apocrine areas "-that is, in the axilla. The cells in this neoplasm have amp le gra nular eosinophilic cytoplasm and the characteris tic decapitatio n secretion."These fea tures were not see n in our pa tie nt's tum or. Malign ant cho ndro id syri ngo ma was excl uded in light of the absence of myxo id and chondroid stroma, which are hall marks of chondroid syringoma.'? Si milarly, malignant eccrine spiradenoma was excluded on the basis of the absence ofbenign eccrine spiradenoma cells. Eccrine spi radenoma is made up of small, primitive-looking basaloid cells that are different from the squamoid ce lls seen in eccrine acros piroma."
Reports in the literature consisten tly emp hasize the slow growth rate of both malign ant and benig n eccri ne acrospirom as. Although MEAs usually arise de novo, 354 malign ant transformation in long-standing lesion s can occur. Hunt et al rep orted a case of ME A that had been present for 40 yea rs, whic h stro ngly suggests a malignant tra nsformation of a pre -existing beni gn tumor ." Ou r patient's tumor had been present for 20 years, and the fact that his biopsy specimen yie lded histologic evidence of both benign and malignant components again suggested a malignant transformation.
Benign eccrine acrospiromas range in size from 0.5 to 12 em , while ma lignant forms tend to be of mo derate size; the largest reported malignant tum or was 4 cm.I.2.5.12 Some MEAs have bee n reported to pro duce a serous discharge, while others have been described as ulcerated lesions.i.s.s Th e clinical simi lari ty of malignant and ben ign eccrine acrospiromas to other cuta neo us lesions (e.g ., hem angiomas , squamous cell carcinomas, basal cell carcinomas, and malignant melanomas) necessitates a histologic diagnosis. A diagnosis of MEA can be arbitrary because there are no strict diagnostic criteria set fort h in the literature. Fea tures that disting uis h mal igna nt from benign eccrine acrospiromas incl ude pleomorphism, atypical mitot ic figures, infiltrative pattern s, and perineural and angiolymphatic invasion.1,4.5.13 W hen present , ben ign co mpo nents with ducts and bland po lyhedra l squamoid cells adjacent to ma lignant tiss ue can fac ilitate and ensure the diagnosis, as happened in the case presented here (figure 1). The presence of benign tiss ue provides a valuab le poi nt of reference for diagnosing poorly differentiated adjacent malignant tissue. However, the detection of both benign and malignant tiss ue in the same tumor often necessitates mu ltiple biopsies to pre clude a sam pling error. In our case, the diagnosis was unequivocal.
Alth ough histology is used to distin gu ish beni gn fro m ma lignant eccrine spiromas, there have been reports of tumors with bland tissue arc hitecture tha t rec urre d locally or metastasized .P :" Similarly, there are cases of eccrine acrospiromas with atypical nuclear changes and cell ular pleomorphism that are clinically benign .' Close followup of all eccri ne acrospiromas is necessary because histology is not always a reliab le indicator of bio logic behavior.
Ma lignant eccrine acrospiromas tend to progress in a predictable patte rn fro m the tumo r site to regional lymph nodes and ultimately to sys temic metastases." Treatm ent consis ts of wide local excision. Som e authors advocate Mohs' surgery initially to deb ulk the clinically apparent tumor and to determine the extent of its subcl inical spread.':" Local tumor removal is important for lesions of uncertain behavior and histology. The risk oflocal recurrence has bee n reported to approach 50 %, and metastatic rates are closer to 60 %.1 5 Altho ugh the metastatic rate is high , there is no ge neral recommendation in the literature for elec tive neck dissection without clinically apparent ade nopa thy.' There have been report s that acrospiromas are radioresistant , but these reports did not include infor mation regardin g the specific technique, the volume radiated, or the cumul ative dose administere d.P-" Locoregional irradiation might be beneficial in malignant tumors at risk for local recurrence.13 Several factors are associ ated with an increased incid ence oflocal recurrence, including derm al lymphatic invasion, perineural invasion, deep structure infiltr ation, positive resecti on margins, highly anaplastic morpholo gy, and extracapsular lymph node extension." Various anecdotal reports indicate that these tumo rs are resistant to chemotherapy. 16 
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